APARITO LIMITED

Company number 09285366 ·

Active

Free AI analysis

Have an AI read this company's filings and write an assessment — financial health, risks, and what the numbers say.

Get the analysis

Shareholders' funds

£15,025,818

Balance sheet as at 2024-12-31

View full accounts →

Overview

Company type
Private Limited Company
Incorporated
2014-10-29
Employees
28 (2024 accounts)
Registered office
Ty Dewi Sant, Rhosddu Road, Wrexham, Wales, LL11 1NF
Postcode
LL11 1NF
Capital
216 GBP
Accounts category
Total Exemption Full

Accounts

Last made up to
2024-12-31
Next due by
2026-09-30
Financial year end
31 December

Confirmation statement

Last statement dated
2025-10-28
Next due by
2026-11-11
View filing history →

Nature of business (SIC)

  • 72110 Research and experimental development on biotechnology

Officers 2 current · 10 resigned

Appointed 2025-08-08
Appointed 2024-08-01

View all officers and resignations →

Group structure

Controlled by Eli Lilly And Company (183025-143) — since 2024-05-24

From persons-with-significant-control filings on the public register.

Public contracts won 1

£220,000 total awarded value where published.

Contains public sector information licensed under the Open Government Licence v3.0 (Contracts Finder).

Contact details

Website
aparito.com
Phone
+44 1978896191

Aparito brings clinical trials to patients and unlocks real-world data through mobile apps, video assessments & wearable devices.

Previous registered addresses 1

AddressChanged on
25A RITSON ROAD LONDON, E8 1DE2017-09-28

Among its peers

Top 10%

by shareholders' funds, of 17 similar companies in LL

The largest employer among its local peers (28 staff).

Trading since 2014.

24 companies are registered at this postcode →

Competitors Wrexham

This company ranks 1 among research and experimental development on biotechnology in Wrexham.

Full league table →

The class of 2014

38%

of the 357 companies in this sector incorporated in 2014 are still active today; 59% have since been dissolved.

A fact about the year, not a forecast for this company.